Pharmacokinetics and tolerability of controlled-release levodopa/carbidopa versus levodopa/carbidopa/entacapone in healthy volunteers.

Trial Profile

Pharmacokinetics and tolerability of controlled-release levodopa/carbidopa versus levodopa/carbidopa/entacapone in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Feb 2011

At a glance

  • Drugs Levodopa/carbidopa; Levodopa/carbidopa/entacapone
  • Indications Parkinson's disease
  • Focus Pharmacokinetics
  • Sponsors Orion Pharma
  • Most Recent Events

    • 09 Feb 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top